Analysis of Pyridate and its metabolite Pyridafol by QuEChERS and LC-MS/MS

Similar documents
EURL-SRM - Analytical Observations Report

Matrix-induced Signal Enhancement of Propamocarb in LC-MS/MS

EURL-SRM - Analytical Method Report. Analysis of Residues of Carbofuran (sum) Using QuEChERS Method

EURL-SRM - Analytical Observations Report

Analysis of Organotin-Pesticides by the QuEChERS Method - Impact of acidifying on the recoveries

EURL-SRM - Analytical Observations Report

Determination of Prochloraz (sum) via its Metabolites

Determination of Prochloraz (sum) via its Metabolites

Improvement of Ethoxyquin Recoveries by QuEChERS Through the Addition of Ascorbic Acid Initiator/Institution: EURL-SRM

Validation Report 23 B

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Analysis of Limonin in Citrus Juice Using QuEChERS and LC-MS/MS

Review of the existing maximum residue levels for chloridazon according to Article 12 of Regulation (EC) No 396/2005

Determination of Chlorophenoxyacetic Acid and Other Acidic Herbicides Using a QuEChERS Sample Preparation Approach and LC-MS/MS Analysis

Validation Report 20

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Validation Report 8. EURL for Cereals and Feeding stuff National Food Institute Technical University of Denmark

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

EVEN QUICKER,CHEAPER AND SAFER GERMAN-MADE FOR YOUR MULTIPLE METHODS

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

COMMISSION REGULATION (EU) / of XXX

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Pesticide Residue Analysis in Whole Milk by QuEChERS and LC-MS/MS

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

EURL-SRM - Analytical Observations Report

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Council of the European Union Brussels, 5 December 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Council of the European Union Brussels, 12 August 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Application Note. Author. Abstract. Introduction. Food Safety

Fast, Robust and Reliable Method for the Identification and Quantitation of Sildenafil Residue in Honey using LC-MS/MS

Rapid Analysis of Bisphenols A, B, and E in Baby Food and Infant Formula Using ACQUITY UPLC with the Xevo TQD

5.23 PROPAMOCARB (148)

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Development of a Multiresidue Method for Analysis of Acidic Pesticides in Cereals with Liquid Chromatography-Tandem Mass Spectrometry

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

[ APPLICATION NOTE ] Oasis PRiME HLB Cartridge for Cleanup of Infant Formula Extracts Prior to UPLC-MS/MS Multiresidue Veterinary Drugs Analysis

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Neosolaniol. [Methods listed in the Feed Analysis Standards]

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Review of the existing maximum residue levels (MRLs) for chlorpropham according to Article 12 of Regulation (EC) No 396/2005 1

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

Council of the European Union Brussels, 4 November 2015 (OR. en)

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Determination of Pharmaceutical Residues in Bovine Milk via LC MS/MS Following Solid Phase Extraction

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Reasoned opinion on the review of the existing maximum residue levels (MRLs) for metazachlor according to Article 12 of Regulation (EC) No 396/2005 1

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Application Note No. 119/2013 Determination of bisphenol A in preserved food SpeedExtractor E-916: Determination of bisphenol A in preserved food

MALAYSIAN MALAYSIAN COCOA WORKSHOP ON THE SAFE USE OF PESTICIDES IN COCOA AND HARMONIZED

Abstract. Introduction

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Author. Introduction. Small Molecule Pharmaceuticals & Generics

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Rapid Screening and Quantitation of Pesticide Residues in Cannabis by Modified QuEChERS and LC-MS-MS

SUPPORTING INFORMATION FOR: CONCENTRATIONS OF POLYBROMINATED DIPHENYL ETHERS, HEXABROMOCYCLODODECANES AND TETRABROMOBISPHENOL-A IN BREAST MILK FROM

Dienes Derivatization MaxSpec Kit

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO

POSITION PAPER No Analysis of Acidic Herbicides with respect to the related residue definitions

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Enhanced LC-MS Sensitivity of Vitamin D Assay by Selection of Appropriate Mobile Phase

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

CONTENT. i iv ix. SVKM s NMIMS, School of Pharmacy and Technology Management

POSITION PAPER No Phthalimid - Part 2: Unavoidable Artefact!

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Direct Analysis of Folic Acid in Digestive Juices by LC/TOF-MS Application

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

Simultaneous Quantitative Analysis of Total Catecholamines and Metanephrines in Urine Using CLEAN UP CCX2 and LC-MS/MS

Combined review of the existing maximum residue levels (MRLs) for the active substances metalaxyl and metalaxyl-m

Simultaneous Analysis of Active Pharmaceutical Ingredients and Their Counter-Ions Using a Mixed-Mode Column

Uptake and Metabolism of Phthalate Esters by Edible Plants

REQUIREMENTS FOR ACCREDITED LABORATORIES APPLYING FOR A FLEXIBLE SCOPE FOR ANALYSIS OF PESTICIDE RESIDUES IN FOOD AND FEED

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Determination of Amantadine Residues in Chicken by LCMS-8040

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Application Note: 425. Introduction. Goal. Experimental Conditions

REASONED OPINION. European Food Safety Authority 2, 3. European Food Safety Authority (EFSA), Parma, Italy

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Transcription:

Observations concerning a compound a matrix a method other Analysis of Pyridate and its metabolite Pyridafol by QuEChERS and LC-MS/MS Reported by: EURL-SRM Version 1 (last update: 30.03.2015) Brief description of problem/observation/solution: The residue definition of pyridate includes pyridate itself and its degradant pyridafol (which is the actual active component) as well as the conjugates of the latter. In recovery experiments using QuEChERS it was observed that pyridate partially degrades and that the acidic pyridafol experiences losses during dspe cleanup when PSA sorbent is used. Skipping dspe with PSA practically quantitative recoveries of pyridate parent and pyridafol are achieved. Simultaneous analysis of parent and metabolite is possible but analysis of the metabolite alone is preferable as degradation of pyridate to pyridafol in calibration solutions leads to biased results and increases analytical uncertainty. In addition the residue definition requires the release of conjugated pyridafol thus suggesting total conversion of pyridate and pyridafolconjugates to pyridafol. Unfortunately the behavior of the conjugates could not be studied as no samples with incurred pyridate were available. All experiments thus focused on the parent and the free metabolite. Several variations of the QuEChERS method were tested with two main aims: a) to find conditions where the recoveries of pyridate are quantitative, and b) to find conditions where pyridate is fully converted to pyridafol. In-source fragmentation of pyridate to pyridafol was observed in LC-MS/MS analysis indicating that chromatographic separation of the two is needed. Compound profile: Pyridate is a post-emergence herbicide that is used for broadleaved weed and grass control in cereals (e.g. maize, rice), brassica crops (e.g. cauliflowers, kohlrabi, broccoli, Brussels sprouts, kale), allium crops (onions, shallots, chives, leek) and other crops (salsify, asparagus, fodder beet, lupins, herbs, rape). The compound is systemic and hydrolyzes within the plant to the active component pyridafol (3-phenyl-4-hydroxy-6-chloropyridazine), which acts as a photosynthesis inhibitor. Page 1 of 6

Table 1: Properties of pyridate and pyridafol at a glance Parameter Value Notes Pka - LogP 6.61 calcutated Water solubility 1.49 (20 C; ph 7) Hydrolytic behavior ISO common name Residue definition EU ph and temperature sensitive: DT50: 4.9 d @ ph 4 / 25 C, 0.44 d @ ph 4 / 50 C, 0.28 d @ ph 9 / 25 C, 0.3 h @ ph 9 / 50 C O-6-chloro-3-phenylpyridazin-4-yl S-octyl thiocarbonate Plant Origin: Pyridate (sum of pyridate, its hydrolysis product CL 9673 (6-chloro-4- hydroxy-3-phenylpyridazin) and hydrolysable conjugates of CL 9673 expressed as pyridate) Animal Origin: CL 9673 expressed as pyridate 1 Approved in Main metabolite BE, CY, CZ, DE, EE, FI, FR, HU, IE, IT, LT, LU, LV, MT, NL, PL, SI, SK, UK, PT in progess Pyridafol = CL 9673 = 6-chloro-3-phenylpyridazin-4-ol (ISO common name) Pka = 6.7 (weak acid) LogP = ph dependent 2.0 @ ph 4 0.56 @ ph 7-0.52 @ ph 9 Experiments conducted and observations: Standards: Pyridate (purity 94%), purchased from Dr. Ehrenstorfer (Cat #: 16640000) Pyridafol (purity 98%) purchased from Dr. Ehrenstorfer (Cat #: 11417500) Note: Stock solutions were prepared considering purity indications of the provider 1 Following feeding studies pyridate was never encountered. Pyridafol was the main fraction, e.g. 70% of TRR in milk (http://www.efsa.europa.eu/en/efsajournal/doc/2687.pdf) Page 2 of 6

Extraction method: In order to explore the degradation behavior of pyridate during QuEChERS sample preparation a number of recovery experiments using variations of the QuEChERS method were conducted. Pyridate and pyridafol were spiked into separate sample portions and analysis was conducted by LC-MS/MS. Samples spiked with pyridate were additionaly analyzed for pyridafol to check whether the share of pyridate that is degraded during sample preparation is quantitatively transformed to pyridafol. The results of this experiment are summarized in Table 4. Measurement: Table 2: Instrumentation details for Pyridate and Pyridafol: LC-MS/MS method: LC WATERS Acquity UPLC MS/MS ABSCIEX API 4000 Q-Trap, run in ESI positive mode MRMs Pyridate 379/207, 379/351, 381/209 MRMs Pyridafol 207/68, 209/104 Column Acquity BEH C18, 2.1x100 mm, 1.7 µm Pre-column Acquity BEH C18, 2.1x5 mm, 1.7 µm Mobile Phase A: 5 mmol NH 4 formate in purified water + 5% Methanol B: 5 mmol NH 4 formate in Methanol Gradient Time Mobile Phase A Mobile Phase B % min % 0 90 10 5 10 90 5.1 10 90 11 90 10 Flow 0.4 ml min -1 Injection volume 2 µl, partial loop with needle overfill Column temperature 40 C Internal Standard Chlorpyrifos D10 Tab. 3: LC-MS/MS mass Transitions for Pyridate and Pyridafol (ESI-positive mode): Compound Tune First Second Sensitivity Mass Mass DP EP CEP CE CXP Mode Pyridate 1 379 207 41 12 16 25 4 ESI pos Pyridate 2 379 351 41 12 16 37 4 ESI pos Pyridate 3 379 209 41 12 16 27 4 ESI pos Pyridafol 1 207 68 46 6,5 14 29 4 ESI pos Pyridafol 2 207 77 46 6,5 14 43 4 ESI pos Pyridafol 3 207 104 46 6,5 14 49 4 ESI pos Pyridafol 3 209 77 46 6,5 14 49 4 ESI pos Note: Pyridafol can be also measured in the ESI-neg. mode. Mass transitions: 205>66; 205>35 and 207>66 Page 3 of 6

Table 4: Recovery rates of Pyridate and Pyridafol. In the case of Pyridate recoveries are shown for pyridate as such as well as for the sum of Pyridate and Pyridafol expressed as Pyridate Spiked compound: Spiked compound PYRIDATE PYRIDAFOL @ 0.1 mg/kg @ 0.1 mg/kg Recoveries Pyridate [%] Recoveries Pyridate [%] Recoveries Pyridafol [%] (Remaining (Pyridafol formed Total Pyridate) during extraction recovery expr. as Pyridate) ( ) # Matrix QuEChERS-Conditions n 1 n 2 n 1 n 2 n 1 n 2 1 Raspberry (acidic) As CEN 15662, without cleanup 103 103 103 2 2 2 105 102 110 106 2 Cucumber As CEN 15662, without cleanup 102 101 101 2 2 2 104 95 93 94 3 Cucumber 4 Cucumber As CEN 15662 (standard method) (with dspe using PSA + immediate acidification with formic acid) As CEN 15662 but acidification w. formic acid after 1 hour 72 75 74 28 27 27 101 83 83 83 64 59 62 35 36 35 97 82 81 82 5 Cucumber 6 Cucumber 7 Cucumber As CEN 15662 but acidification w. formic acid after 7 hours 33 29 31 81 81 81 112 83 81 82 QuEChERS (modified) (EURL-Method for Chlorothalonil 2 involving acidification w. sulfuric acid prior to extraction) 103 99 101 2 2 2 103 90 94 92 QuEChERS (modified) (EURL-method for Nicotine involving add. of NaOH prior to extraction 0 0 0.0 109 111 110 110 91 91 91 to reach ph ~11) and no cleanup 3 In-source fragmentation Considerable in-source fragmentation of pyridate to pyridafol was noticed in LC-MS/MS resulting in large signals at the mass-traces of pyridafol. For example: injecting a pyridate at ca. 0.1 µg/ml in the ESI pos. mode resulted in a pyridafol signal at the retention time of pyridate corresponding to ca. 0.08 µg/ml pyridate (following mathematic conversion of pyridafol to pyridate), see Figure 1. In-source fragmentation seems to take place reproducibly thus accuracy of measurement is not affected. However, in case the pyridafol signal formed through insource fragmentation is missallocated to pyridafol as such would result in an excessive overestimation of total pyridate. This should particularly be kept track of where pyridafol is measured in the ESI-neg. mode without having a feedback on the retention time of pyridate. 2 http://www.crl-pesticides.eu/library/docs/srm/meth_quechersforchlorothalonil_2010.pdf 3 http://www.crl-pesticides.eu/library/docs/srm/meth_nicotinemushrooms_crlfvcrlsrm.pdf Page 4 of 6

Figure 1: Chromatograms of Pyridate and Pyridafol resulting after a recovery experiment of pyridate at 0.1 mg/kg on cucumber using QuEChERS but without any cleanup step (no PSA), ( #2, n1 in Table 4). Pyridate: 0.102 mg/kg (Recovery: 102%) Pyridafol (calc. as Pyridate): 0.002 mg/kg (Recovery: 2%) Pyridafol resulting from in-source fragmentation of pyridate. Signal corresponds to 0.044 mg/kg pyridafol (= ca. 80% recovery if calculated as pyridate) Figure 2: Chromatograms of Pyridate and Pyridafol resulting after a recovery experiment of pyridate at 0.1 mg/kg on cucumber using QuEChERS without dspe using PSA but with delayed re-acidification ( #5, n1 in Table 4). Pyridate 0.033 mg/kg (Recovery: 33%) Pyridafol (calc. as Pyridate): 0.081 mg/kg (Recovery: 81%) Page 5 of 6

Figure 3: Chromatograms of Pyridate and Pyridafol resulting after a recovery experiment of pyridate at 0.1 mg/kg on cucumber using modified QuEChERS with extraction under alkaline conditions ( #7, n1 in Table 4). Pyridate: n.d. (0%) Pyridafol (calculated as Pyridate): 0.109 mg/kg (109%) Discussion and conclusions: The results clearly show the following: a) For both pyridate and pyridafol quantitative recoveries can be achieved using QuEChERS (EN-15662) without cleanup (skipping dspe-cleanup with PSA), b) During dspe-cleanup with PSA pyridate and pyridafol experience losses. Pyridate due to degradation and the acidic pyridafol (pka = 6.7) due to interaction with PSA. c) The transformation of pyridate to pyridafol is typically quantitative d) Analysis of pyridate and pyridafol next to each other is possible but keeping them in separate calibration solutions is indicated to maintain the ability to monitor the degradation of pyridate to pyridafol in solution and avoid errors if this takes place unnoticed. e) A quantitative conversion of pyridate to pyridafol during analysis is possible by raising the ph either during extraction or of the final extract. f) Considerable in-source fragmentation of pyridate to pyridafol was noticed in LC- MS/MS but this seems to take place in a reproducible manner and as long as chromatographic separation between pyridate and pyridafol exists this does not affect the accuracy of analysis. This should be particularly kept track of where pyridafol is measured in the ESI-neg. mode without having feedback on the retention time of pyridate. g) More experiments will follow as soon as commodities with incurred residues and conjugated pyridafol become available. References: EFSA Journal 2012;10(4):2687 : Reasoned opinion on the review of the existing maximum residue levels (MRLs) for pyridate according to Article 12 of Regulation (EC) No 396/20051, http://www.efsa.europa.eu/en/efsajournal/doc/2687.pdf Page 6 of 6